Article in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Anna CampainThe George Institute for Global Health, UNSW Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0003-1057-0085
Ognjenka DjurdjevBC Provincial Renal Agency, Vancouver, British Columbia, Canada.
Amit X GargICES, Toronto, Ontario, Canada.
Ziv HarelDivision of Nephrology, St. Michael's Hospital, Toronto, Ontario, Canada.ORCID 0000-0002-8618-4538
Brenda HemmelgarnFaculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Carinna HockhamThe George Institute for Global Health, Imperial College London, London, United Kingdom.ORCID 0000-0003-2126-5350
Matthew T JamesDivision of Nephrology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-1876-3917
Meg J JardineNHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-0160-2375
Adeera LevinVancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0003-2438-8401
Eric McArthurICES, Toronto, Ontario, Canada.
Pietro RavaniDivision of Nephrology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-6973-8570
Selena ShaoBC Provincial Renal Agency, Vancouver, British Columbia, Canada.ORCID 0009-0009-7076-4261
Manish M SoodDepartment of Medicine, The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.ORCID 0000-0002-9146-2344
Zhi TanDivision of Nephrology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-3247-621
Navdeep TangriDepartment of Internal Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada.
Reid WhitlockDepartment of Internal Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada.ORCID 0000-0002-7046-0358
Martin GallagherThe George Institute for Global Health, UNSW Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0001-9187-6187
Min JunThe George Institute for Global Health, UNSW Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0003-1460-7535
Jeffrey T HaThe George Institute for Global Health, UNSW Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0002-8558-1697
Funding
National Health and Medical Research Council 1148060
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cardiovascular diseaseCKDepidemiology and outcomesGFR
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based Study. · full record | OpenQuestion